Peringkat dalam Saham
#41014
PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery... PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery platform technology, having successfully transitioned into the commercial stage. The company's primary offerings include Vazalore 325 mg, which is formulated for individuals facing vascular incidents like heart attacks and clot-induced strokes, as well as for the management of pain and inflammation. Additionally, they provide Vazalore 81 mg in the form of liquid-filled aspirin capsules. Looking ahead, their product development pipeline features PL1200 Ibuprofen 200 mg and PL1100 Ibuprofen 400 mg, both of which are in Phase I clinical trials for addressing pain, inflammation, and fever. PLx Pharma makes its products available to consumers through a variety of retail avenues, including pharmacies, major retailers, supermarkets, and online sales channels. Founded in 2002, PLx Pharma Inc. is headquartered in Sparta, New Jersey.
Harga Saham
$0.00575
Terakhir disinkronkan: 2023-05-23
Kapitalisasi Pasar
$51.30K
Perubahan (1 hari)
-17.86%
Perubahan (1 tahun)
0.00%
Perdagangan PLx Pharma Inc. (PLXP)
Harga PLXP dengan kapitalisasi pasar B
Kapitalisasi pasar dari PLx Pharma Inc.(PLXP)
Kapitalisasi Pasar: $51.30K
Per August 2026, PLx Pharma Inc. memiliki kapitalisasi pasar sebesar $51.30K. Ini menjadikan PLx Pharma Inc. sebagai perusahaan 41014th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar PLx Pharma Inc. dari 2014 hingga 2026
PLXP dibandingkan dengan 5 teratas stocks paling populer
| Harga PLXP |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.470T
|
+10,662,337,937.50%
|
|
|
|
|
$4.467T
|
+8,708,125,730.73%
|
|
|
|
|
$4.174T
|
+8,137,564,781.05%
|
|
|
|
|
$3.700T
|
+7,212,944,876.35%
|
|
|
|
|
$2.854T
|
+5,564,266,566.07%
|
